Eli Lilly has received approval from the Ministry of Health, Labour and Welfare (MHLW) in Japan for Kisunla (donanemab-azbt) ...
While grilling Novo Nordisk’s chief executive over the price of its blockbuster diabetes and weight-loss drugs, Ozempic and ...
The "Usher Syndrome - Pipeline Insight, 2024" report has been added to ResearchAndMarkets.com's offering.A comprehensive insight into the Usher Syndrome pipeline landscape highlights promising ...